Individuals harboring POLG-, TYMP-, or MPV17- deletions or m.8993T>G and m.8993T>C mtDNA mutations, as well as those affected by SURF1-related mitochondrial diseases are at greater risk of developing peripheral neuropathy. This evidence concerns the gene MPV17 and inborn mitochondrial metabolism disorder.